trisaluslifesci.comHealthcare / BioTech & PharmaFounded: 2009Funding to Date: $198.81MM
TriSalus Life Sciences is a biopharma company that specializes in treatment research and development for tumors of the liver and pancreas. TriSalus involves a team of clinicians and scientists who develop systemic immunotherapies to fight tumors through its developed drug delivery methods.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
10/05/2022 | Series B-2 | $15.32MM | $xx.xx | $375.88MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
43,775,511
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
09/29/2021 | Series B-3 | $17.14MM | $xx.xx | $356.56MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
342,857,136
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
09/29/2021 | Series B-1 | $23.5MM | $xx.xx | $356.56MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
67,142,854
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/18/2021 | Series B | $85.22MM | $xx.xx | $161.99MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
284,065,377
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/02/2017 | Series A-6 | $16.3MM | $xx.xx | $80.61MM | Ori Healthcare Fund | |
Price per Share
$xx.xx
Shares Outstanding
32,601,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ori Healthcare Fund
|
||||||
12/02/2015 | Series A-4 | $2.05MM | $xx.xx | $55.51MM | High Country Venture, Kmg Capital Partners, Mcg Partners, Partisan Management Group, Tullis Health Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,169,690
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
High Country Venture, Kmg Capital Partners, Mcg Partners, Partisan Management Group, Tullis Health Investors
|
||||||
12/02/2015 | Series A-5 | $13.08MM | $xx.xx | $55.51MM | High Country Venture, Kmg Capital Partners, Mcg Partners, Partisan Management Group, Tullis Health Investors | |
Price per Share
$xx.xx
Shares Outstanding
29,715,910
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
High Country Venture, Kmg Capital Partners, Mcg Partners, Partisan Management Group, Tullis Health Investors
|
||||||
11/07/2013 | Series A-2 | $9.02MM | $xx.xx | $45.95MM | Mcg Partners, Partisan Management Group & High Country Ventures | |
Price per Share
$xx.xx
Shares Outstanding
23,307,464
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Mcg Partners, Partisan Management Group & High Country Ventures
|
||||||
11/07/2013 | Series A-3 | $10.66MM | $xx.xx | $45.95MM | Mcg Partners, Partisan Management Group & High Country Ventures | |
Price per Share
$xx.xx
Shares Outstanding
24,792,020
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Mcg Partners, Partisan Management Group & High Country Ventures
|
||||||
07/06/2011 | Series A-1 | $6.53MM | $xx.xx | $18.65MM | High Country Venture, Partisan Management Group | |
Price per Share
$xx.xx
Shares Outstanding
5,331,943
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
High Country Venture, Partisan Management Group
|